-
Drug Discovery & Therapeutics2 weeks agoOno Pharmaceutical joins forces with Aitia for drug discovery in neurology
The agreement will see Aitia apply its REFS technology to build Gemini Digital Twins (GDTs) of neurological conditions to identify potential new therapeutic targets and biomarkers....
-
Regulatory Intelligence & Drug Approvals2 weeks agoTakeda and Weave Bio collaborate on AI-driven automation in drug development
The partnership aims to integrate Weave Bio’s AI tools with Takeda’s regulatory experience to streamline workflows within the regulatory process. The joint effort began with the...
-
Regulatory Intelligence & Drug Approvals2 weeks agoPharmaEssentia’s Besremi receives FDA approval for ET
This marks the first FDA-approved treatment for ET in nearly 30 years. The approval is based on data from the global Phase III SURPASS ET trial,...
-
Capital, M&A & Industry Strategy2 weeks agoKazia closes oversubscribed offering to fund paxalisib’s clinical development
These proceeds will support the planned and ongoing studies of Kazia’s lead investigational therapy, paxalisib, in triple-negative breast cancer, hormone receptor positive/human epidermal growth factor receptor...
-
Capital, M&A & Industry Strategy3 weeks agoTeva Pharmaceuticals to acquire BioXcel assets for up to $125m
The agreement arises as part of BioXcel Therapeutics’ voluntary Chapter 11 proceedings in the US Bankruptcy Court for the District of Delaware, initiating a court-supervised sale...
FDA Approves Fayuvi (rebisufligene etisparvovec-hopf) Gene Therapy for the Treatment for Sanfilippo Syndrome Type A (MPS IIIA)
Novo’s Denecimig Demonstrates Tolerability After Switch from Emicizumab in FRONTIER5 Study of People with Haemophilia A as Published in the Journal of Thrombosis and Haemostasis
Bayer’s Kerendia (finerenone) Receives FDA Approval as the First New Treatment in 30 Years for Adults with Chronic Kidney Disease (CKD) and Type 1 Diabetes
Scientists turn pig semen extract into eye drops that kill cancer in mice
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
